J. THORNTON to Adult
This is a "connection" page, showing publications J. THORNTON has written about Adult.
Connection Strength
0.335
-
Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study. Harm Reduct J. 2024 Dec 20; 21(1):220.
Score: 0.038
-
Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study. BMJ Open. 2024 May 30; 14(5):e082339.
Score: 0.036
-
Patients' willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States. J Am Pharm Assoc (2003). 2024 May-Jun; 64(3):102062.
Score: 0.036
-
Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. J Occup Environ Med. 2024 Mar 01; 66(3):226-233.
Score: 0.035
-
Differences in Perceived Threat and Efficacy in Managing Opioid Use Disorder versus Alcohol Use Disorder. Subst Use Misuse. 2023; 58(10):1187-1195.
Score: 0.034
-
Intention to get naloxone among?patients prescribed opioids for chronic pain. Harm Reduct J. 2022 Sep 22; 19(1):104.
Score: 0.032
-
Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysis. Qual Life Res. 2017 08; 26(8):1955-1967.
Score: 0.022
-
Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S12-S18.e4.
Score: 0.022
-
Car Seat Safety: Typologies of Protective Health and Safety Behaviors for Mothers in West Virginia. Matern Child Health J. 2017 02; 21(2):326-334.
Score: 0.022
-
Impact of automated alerts on discharge opioid overprescribing after general surgery. Am J Health Syst Pharm. 2024 Dec 05; 81(24):1288-1296.
Score: 0.009
-
Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
Score: 0.009
-
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors. Am J Clin Oncol. 2024 Nov 01; 47(11):517-525.
Score: 0.009
-
Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer. 2023 Jul 13; 23(1):655.
Score: 0.009
-
Trends and patterns in the use of opioids among metastatic breast cancer patients. Sci Rep. 2020 12 10; 10(1):21698.
Score: 0.007
-
Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
Score: 0.007
-
Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
Score: 0.007